Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States.

[1]  B. Helfand,et al.  Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation. , 2014, Urologic oncology.

[2]  G. Andriole.  Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer: Bill-Axelson A, Holmberg L, Garmo H, et al (Uppsala Univ Hosp, Sweden; et al) N Engl J Med 370:932-942, 2014 § , 2014 .

[3]  R. Deyo,et al.  ADAPTING A CLINICAL COMORBIDITY USE WITH ICD-g-CM ADMINISTRATIVE INDEX FOR DATABASES , 1992 .

[4]  A. Renshaw,et al.  The impact of a delay in initiating radiation therapy on prostate‐specific antigen outcome for patients with clinically localized prostate carcinoma , 2005, Cancer.

[5]  D. Penson,et al.  Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap , 2010, BJU international.

[6]  Monique J. Roobol,et al.  Mortality Results from a Randomized ProstateCancer Screening Trial , 2009 .

[7]  W. Shadish,et al.  Experimental and Quasi-Experimental Designs for Generalized Causal Inference , 2001 .

[8]  A K Wagner,et al.  Segmented regression analysis of interrupted time series studies in medication use research , 2002, Journal of clinical pharmacy and therapeutics.

[9]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[10]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[11]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[12]  Ruth Etzioni,et al.  Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates. , 2011, Journal of clinical epidemiology.

[13]  Ruth Etzioni,et al.  Overdiagnosis and overtreatment of prostate cancer. , 2014, European urology.

[14]  David Chia,et al.  Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[15]  Monique J. Roobol,et al.  Re: Mortality Results from a Randomized Prostate-Cancer Screening Trial , 2009 .

[16]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[17]  C. Ko,et al.  The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.

[18]  A. Evans,et al.  Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. , 2003, The Canadian journal of urology.

[19]  A D Mickalide,et al.  U.S. Preventive Services Task Force. , 1986, Pediatric clinics of North America.

[20]  Mohammad Hassan Murad,et al.  Early detection of prostate cancer: AUA Guideline. , 2013, The Journal of urology.

[21]  P. Glasziou,et al.  Screening for colorectal cancer using the faecal occult blood test, hemoccult. , 2000, The Cochrane database of systematic reviews.

[22]  Christina Bougatsos,et al.  Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force , 2011, Annals of Internal Medicine.

[23]  P. Carroll,et al.  20-year outcomes following conservative management of clinically localized prostate cancer , 2005 .

[24]  H. Koenig,et al.  Prostate-Specific Antigen-Based Screening for Prostate Cancer , 2011 .

[25]  L. Ponsky,et al.  The impact of recent screening recommendations on prostate cancer screening in a large health care system. , 2013, The Journal of urology.

[26]  P. Maté Mate.  [Radical prostatectomy versus observation for localized prostate cancer]. , 2013, Revista clinica espanola.

[27]  M. Tonelli,et al.  Recommendations on screening for prostate cancer with the prostate-specific antigen test , 2014, Canadian Medical Association Journal.

[28]  Dante diTommaso,et al.  Quantifying the role of PSA screening in the US prostate cancer mortality decline , 2008, Cancer Causes & Control.

[29]  J. Kirkpatrick.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. , 1998, Journal of insurance medicine.

[30]  D. Siemens.  Radical prostatectomy or watchful waiting in early prostate cancer? , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[31]  A. Evans,et al.  Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates. , 2015, The Journal of urology.

[32]  P. Gøtzsche,et al.  Screening for breast cancer with mammography. , 2013, The Cochrane database of systematic reviews.